How many investments has FemHealth Ventures made?

FemHealth Ventures has 24 tracked investments, 1 of which have exited via acquisition or IPO, including 1 dated in the last 24 months.

What stage does FemHealth Ventures invest at?

FemHealth Ventures invests at the Seed, Series A stages.

What sectors does FemHealth Ventures focus on?

FemHealth Ventures focuses on Biotech, Digital Health, FemTech, Healthtech.

Where is FemHealth Ventures located?

FemHealth Ventures is headquartered in Short Hills, US.

Does FemHealth Ventures lead rounds?

FemHealth Ventures typically participates in rounds rather than leading them.

Who does FemHealth Ventures co-invest with?

FemHealth Ventures most often shares deals with Joyance Partners, Ascension Ventures, Delos Capital, among 96 tracked co-investors.

FemHealth Ventures

Venture capitalActively deployingoperating company · company profile

Short Hills · Seed–Series A · 10 people tracked

Also known as FEMHEALTH VENTURES MANAGEMENT LLC

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

FemHealth Ventures invests in women's health innovations, guided by its proprietary FemHealth Framework (first published 2019) that categorizes women's health conditions into three groups: those appearing only in women (e.g. endometriosis, PCOS, cervical cancer), mostly in women (e.g. breast cancer, lupus, multiple sclerosis), and differently in women (e.g. heart disease, diabetes, asthma). The firm emphasizes that biological sex differences at the cellular level mean diseases can present differently in women and require distinct treatment approaches. It views women's health as a large, underserved, high-growth market opportunity while seeking exceptional returns.

Invests inBiotech Digital Health FemTech Healthtech Global United States

Source: firm website, verified Aug 25, 2026.

Stage

Seed–Series A

Short Hills, NJ, US

Leads rounds

Follows

Instruments

Equity

Founded

2019

Last 12 months

1 investment

Private fund assets

$102.4M

VC funds

Tracked investments

Team · 10 people

from the firm's website

Maneesha Ghiya· Managing Partner· New York City Metropolitan Areain

Maneesha Ghiya, a healthcare investor driven by a life-threatening postpartum hemorrhage, has 25+ years in private and public healthcare investing and helped formalize the widely adopted 2019 three-category women's-health framework.

Sara Crown Star· Venture Partner· Chicago, Illinois, United Statesin

Sara Crown Star, President of SCS Innovations, brings company-building experience and a returns-first view treating women's health as an underappreciated economic opportunity across drugs, devices, diagnostics and digital health.

Greg Brown· Advisory Board - Healthcare Royalty Investing Pioneer· Houston, Texas, United Statesin

Gregory B. Brown, M.D. is CEO and a director of Memgen, Inc., a development-stage company working on next-generation viral immunotherapeutics including oncolytic viruses. He co-founded HCR Partners, a healthcare-focused asset management firm, and was previously a partner at Paul Capital Partners where he co-managed royalty investments; earlier he was co-head of investment banking and head of healthcare at Adams, Harkness & Hill and a biotechnology research analyst at Vector Securities International. Trained as a transplantation immunologist and thoracic and vascular surgeon, he holds a B.A. from Yale College, an M.D. from SUNY Upstate Medical Center, and an M.B.A. from Harvard Business School.

Nisha Chakravarty· Impact Executive / Wharton Lecturer· United Statesin

Nisha Chakravarty is an impact executive whose 20-year career spans the social sector, financial services, and publishing, with a focus on expanding access to education, healthcare, and employment through technology and market-based approaches. She currently serves as EVP at Safe Water Network, has founded social enterprises in Ethiopia, India, and Kenya, and previously held CFO and COO roles as well as finance and shared-services positions at Goldman Sachs, Lehman Brothers, Nomura India, TIME, and Scholastic. She lectures on social innovation at The Wharton School and holds an Ed.D. in Artificial Intelligence from the University of Pennsylvania, an M.A. from Columbia University, and a B.S.E. from The Wharton School.

Rache Simmons· Advisory Board - Breast Cancer Surgeon· New York Cityin

Rache Simmons is a breast cancer surgeon who has practiced breast surgery at Weill Cornell Medical Center/New York Presbyterian Hospital for three decades. She is a founding member and Past-President of the American Society of Breast Surgeons, and serves as Associate Dean of Diversity and Inclusion and inaugural Director of the Office of Women at Weill Cornell Medicine. She holds a bachelor's degree and MD from Duke University and an MBA from Cornell University's Johnson School of Business.

Randy Cohen· Advisory Board - HBS Professor· Cambridge, Massachusetts, United Statesin

Randy Cohen (Randolph B. Cohen), PhD, is the MBA Class of 1975 Senior Lecturer of Entrepreneurial Management at Harvard Business School, where he teaches finance and entrepreneurship and leads Field X, a course for MBA students starting businesses. He has previously served as an Associate Professor at HBS and a Visiting Associate Professor at MIT Sloan, and his research covers money manager selection, asset allocation, risk management, municipal securities, cryptocurrency, and longevity insurance. He has helped start and grow several businesses, mainly in investment management, and holds an AB in mathematics from Harvard College and a PhD in finance and economics from the University of Chicago.

Sean Ainsworth· Advisory Board - Biotech CEO· San Francisco, California, United Statesin

Sean Ainsworth is CEO and Chairman of the Board of Immusoft, with over 25 years in biotechnology and pharmaceuticals. He founded and led RetroSense Therapeutics, a gene therapy company sold to Allergan in 2016, and serves as Lead Independent Director at Ocuphire Pharma (Nasdaq: OCUP). He founded Ainsworth BioConsulting in 2004 and holds an MBA from Washington University in St. Louis and a BS in Microbiology from UC San Diego.

Stephan Oppenheimer· Advisory Board - Private Equity Investor· United Statesin

Stephan Oppenheimer is Managing Partner of Pontalba Capital, a private investment firm. He previously spent five years as a Partner at Moelis Capital Partners, where he oversaw the business services practice, and ten years with CCMP Capital (formerly JPMorgan Partners) in New York and London leading U.S. and international investments. He holds a B.S. in Electrical Engineering and an M.B.A. from the Darden Graduate School of Business, both from the University of Virginia.

Stephanie Wang· Investor· New York, New York, United Statesin

Stephanie Wang is an Investor at FemHealth Ventures focused on innovations in women's health. She previously worked as a consultant at ZS Associates, a healthcare-focused management consulting firm, advising pharmaceutical companies on R&D, pricing, value and access, and marketing. She holds a B.A. in Finance and Computer Science from New York University's Leonard N. Stern School of Business.

Susanne Seripiero· Executive Administrator· Woodbury, New York, United Statesin

Susanne Seripiero is the Executive Administrator at FemHealth Ventures, supporting operational functions. She previously served as Executive Assistant to the COO at the New York-based hedge fund Kingdon Capital, and holds a B.A. in English with a concentration in Secondary Education from Kean University.

What they invest in

from 24 of 27 portfolio companies

Healthtech ×21Biotech ×14Medical Devices ×14Digital Health ×5FemTech ×4AI & Machine Learning ×3Deep Tech ×2Robotics ×2

HQs:United States×20

Who they back

founder profiles across 12 portfolio companies

33%

solo founders

4 of 12 mapped founding teams

Founding team size:solo founder×42 founders×43 founders×34+ founders×1

Accelerator rootsportfolio companies that came through a program

Y Combinator ×2

Investments · 27 tracked

founders shown can be your intro path

By year:2026 · 1 2020 · 2 2018 · 14 dated

Raydiant Oxymetryraydiantoximetry.com in✓ verified

Raydiant Oximetry is a clinical-stage medical device company developing Lumerah, a noninvasive fetal pulse oximeter that directly measures fetal oxygen levels using biophotonics and machine learning.

Digital HealthFemTechMedical DevicesSan Ramon, US

Michael Nagel(Chief Executive Officer)

Co-investorsBand of Angels SteelSky Ventures Tri-Valley Ventures Avestria Ventures Bill & Melinda Gates Foundation Rhia Ventures +3 more

Trefoil Therapeuticstrefoiltherapeutics.com in✓ verified

Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.

BiotechHealthtechMedical DevicesSan Diego, US

David Eveleth(Executive Officer, Director)Schalon Newton(Executive Officer)

BoardChristy Shaffer(Director)inRalph Bradshaw(Director)

Co-investorsExSight Ventures Solasta Ventures Access Biotechnology Bios Partners Correlation Ventures Hatteras Venture Partners +2 more

10Beauty10beauty.co in

10Beauty operates robotic manicure stations using single-use pod technology and proprietary nail-strengthening polishes.

ConsumerHealthtechRoboticsWestwood, US

Alex Shashou(Founder & CEO)Willie Litvack(Founder & General Partner)inSean Tolkin(Founder & General Partner)inAlexander Shashouin

Co-investorsAlumni Ventures Basecamp Fund Blue Ivy Ventures Centre Street Partners Formus Capital Good Friends +8 more

Alyssum Therapeutics

Alyssumtxalyssumtx.com in

Alyssum Therapeutics is a clinical-stage biotech developing small-molecule immunotherapies that modulate B cells to treat solid cancers and other complex diseases.

BiotechDeep TechHealthtech

AOA Dxaoadx.com in 𝕏

AOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesDenver, US

Oriana Papin-Zoghbi(Founder)inAlex Fisher(Founder/COO)inAnna Jeter(Founder)inOriana Zoghbi-Harb(Executive Officer, Director)Abigail Mcelhinny(Executive Officer)

BoardSurbhi Sarna(Director)

Co-investorsAlleyCorp Good Growth Capital Joyance Partners Y Combinator Astia Aurum Venture Partners +18 more

BioAestheticsbio-aesthetics.com

BioAesthetics develops NACgraft, a cell-free, collagen-rich nipple-areolar complex graft that a surgeon applies so the patient's own cells integrate it into living nipple and areola tissue.

BiotechHealthtechMedical DevicesNew Materials

Juliana Blum(CEO & Director)Billy Heim(COO)

Co-investorsHemi Ventures, Llc Joyance Partners New Orleans Startup Fund The Launch Place IndieBio

Brixtonbiobrixtonbio.com

Brixton Bio develops Reneurx therapy, a treatment aimed at providing long-lasting pain relief for up to six months from a single administration.

BiotechMedical Devices

Charles Sidoti(Founder)in

Co-investorsAngel Physicians Fund Excelestar Ventures Schooner Capital SV Health Investors

Cerclecercle.ai in

Cercle builds a platform that ingests and transforms healthcare data at scale into insights, with a focus on fertility and reproductive care.

AI & Machine LearningData & InfrastructureFemTechHealthtechSan Francisco, US

Andreas Melder(Co-founder & CEO)Dr. Irene Cuevas(Co-founder & Chief Scientist)Liya Sharif Lancia(Founder)Pran Punniamoorthy(CTO)Lucy Huang(COO)

Co-investorsOutsiders Rogue Womens Fund

Evommuneevommune.com in

Evommune develops therapies targeting the underlying sources of chronic inflammatory diseases, aiming to provide underserved patient populations with more than symptomatic relief.

BiotechHealthtechPalo Alto, US

Luis Pena(Executive Officer, Director)Janice Drew(Executive Officer)David Cohen(Director)Gregory Moss(Executive Officer)Eugene Bauer(Executive Officer, Director)Francois Beaubien(Director)

Co-investorsAndera Partners Avego BioScience Capital B Capital Group B4 Capital Beiersdorf Innovation Fund Longwood Fund +2 more

GT Medical TechnologiesMay 2026 · $100M

GammaTile Therapy, a surgically targeted radiation therapy for operable brain tumors

HealthtechTempe, US

David G. Brachman(Executive Officer, Director)Per Langoe(Executive Officer, Director)James Leech(Executive Officer)Matthew E. Likens(Executive Officer, Director)

BoardGeoff Pardo(Director)inPrattipati Laxminarain(Director)

Co-investorsAccelmed Partners BlueStone Venture Partners Evidity Health Capital Gilde Healthcare Medical Technology Venture Partners MedTech Venture Partners +2 more

Gtmedtechgtmedtech.com in 𝕏

GammaTile is an FDA-cleared, bioresorbable collagen tile embedded with radiation sources, implanted during brain tumor removal surgery to deliver targeted radiation at the surgical site.

BiotechHealthtechMedical Devices

Co-investorsAccelmed Partners BlueStone Venture Partners Evidity Health Capital

Gynesonicsgynesonics.com in 𝕏acquired by Hologic

FemTechHealthtechMedical DevicesRedwood City, US

Christopher Owens(Executive Officer, Director)Darrin Uecker(Executive Officer, Director)Tom Rodgers(Director)

BoardKen Haas(Director)Jonathan MacQuitty(Director)inMike Carusi(Director)in

Co-investorsAmzak Health Bain Capital Life Sciences Endeavour Vision Kaiser Permanente Ventures Kluz Ventures Lightstone Ventures +5 more

Iantrekiantrekmed.com in

Iantrek develops micro-interventional ophthalmic surgical technologies focused on enhancing total outflow through the uveoscleral pathway to treat glaucoma.

BiotechHealthtechMedical DevicesElkins Park, US

Tsontcho Ianchulev(Executive Officer, Director)Sean Ianchulev(Founder & Chairman of the Board (CMO))Michael Haydin(Executive Officer)

BoardJeffry K Weinhuff(Director)Farrell Tyson(Director)Stephen Bloch(Director)in

Co-investorsaMoon Visionary Ventures Canaan Partners Civilization Ventures Management, Llc JSD Capital, LLC US Venture Partners

IgGenix Inc.iggenix.com in

IgGenix is a clinical-stage biotechnology company focused on antibody discovery and development for allergies and immunological diseases.

AI & Machine LearningBiotechHealthtechSouth San Francisco, US

Kari Nadeau(Scientific Co-Founder)

Co-investorsKhosla Ventures Allerfund Ventures, Llc Global Brain Medical Incubator Japan K.K.ShangBay Capital LLC SBI Investment

Imperative Care Incimperativecare.com in 𝕏

Imperative Care develops medical technologies for treating stroke and other vascular diseases, aiming to address gaps across the patient care journey.

HealthtechMedical DevicesCampbell, US

Farhad Khosravi(Executive Officer, Director)Matthew Garrett(Executive Officer)Charles Alpuche(Executive Officer)Scott Elliott(Executive Officer)

BoardJames Rogers(Director)Stacy Enxing Seng(Director)

Co-investorsAscension Ventures Delos Capital Lightstone Ventures

inSoma Bioinsomabio.comJun 2020

inSoma Bio develops biomaterial products for reconstruction plastic surgery, enabling surgeons to use patients' own tissue instead of synthetic implants and fillers for breast and facial reconstruction procedures.

BiotechHealthtechMedical DevicesDurham, US

Stefan Roberts(Founder)inAshutosh Chilkoti(Founder)in

BoardScott Hollenbeck(Lead Medical Advisor)Juliana Blum(Director)Heather Brennan(Director)June S. Almenoff(Director)

Co-investorsDuke Capital Partners Y Combinator

Kanvas Biokanvasbio.com in 𝕏

Kanvas Bio operates a full-stack microbiome drug discovery platform, using a spatial mapping engine to image host-microbiome interactions and in-house manufacturing to produce live biotherapeutics.

BiotechDeep TechHealthtechMonmouth Junction, US

Matthew Cheng(Executive Officer, Director)Hao Shi(Executive Officer, Director)Iwijn De Vlaminck(Executive Officer, Director)

BoardJason Pontin(Director)inJustin Smithline(Director)in

Co-investorsBascom Ventures Boutique Venture Partners DCVC (Data Collective)Germin8 Ventures Kicker Ventures Pangaea Ventures Us Inc.+2 more

Mendaeramendaera.com in 𝕏

Mendaera builds robotic technology, including its Focalist System for robotic-guided access and procedures such as transplant biopsy, to help healthcare providers perform reproducible clinical procedures.

Digital HealthHealthtechMedical DevicesRoboticsSan Mateo, US

Josh DeFonzo(Founder)inJason Wilson(Founder)

Co-investorsThreshold Ventures Founders Fund Lux Capital Averin Capital Sonder Capital Mana Ventures +1 more

Microbiome Therapeutics in

HealthtechNew Orleans, US

Mark Heiman(Executive Officer)Dale Pfost(Executive Officer, Director, Promoter)

BoardDon Marvin(Director)Richard Montgomery(Director)Ross Barrett(Director)John Elstrott(Director, Promoter)

Co-investorsSofinnova Ventures Bayern Kapital DCVC (Data Collective)Pangaea Ventures

NextNews

Nymbl Sciencenymblscience.com

HealthtechDenver, US

Edward Likovich(Executive Officer, Director)James Cook(Executive Officer, Director, Promoter)

BoardThomas Virden(Director)Ben Wire(Director)inChris Saxman(Director)Rohit Seth(Director)

Co-investorsAllied Venture Partners Cobalt Ventures Forefront Venture Healthtech Capital Rockies Venture Club Social Starts +2 more

Ossium Healthossiumhealth.com in 𝕏May 2018

Ossium Health develops cellular therapies and bioengineered products for clinical use, leveraging adult stem cell technologies and advanced cell processing platforms.

BiotechHealthtechMedical DevicesSan Francisco, US

Kevin Caldwell(CEO, Co-Founder & President)inDr. Woods(Chief Science Officer, Co-Founder, EVP, CLIA Laboratory Director)Sebastian Giwa(Director)Erik Woods(Founder)in

BoardWilliam Trenchard(Director)inThomas Cycyota(Director)

Co-investorsHemisphere Ventures LLC Manta Ray Ventures Vivo Capital XYZ Venture Capital First Round Capital Village Global

Oximetry

Rejonirejoni.com inSep 2020

Rejoni is a company focused on uterine health, developing technology to address women's reproductive and gynecological health needs.

BiotechFemTechHealthtechMedical DevicesBedford, US

AMARPREET SAWHNEY(Executive Officer, Director, Promoter)inAmar Sawhney(Founder)NICK SVENCER(Executive Officer, Director, Promoter)FARHAD KHOSRAVI(Executive Officer, Director, Promoter)

BoardTARA BUTLER(Executive Officer, Director, Promoter)

Co-investorsAscension Ventures ClavystBio Delos Capital Iyengar Capital Partners Amed Ventures Catalyst Health Ventures

Reunion Neurosciencereunionneuro.com in 𝕏

Reunion Neuroscience is a clinical-stage biopharmaceutical company developing serotonergic psychedelic therapies for mental health conditions such as postpartum depression, adjustment disorder, and generalized anxiety disorder.

BiotechDigital HealthMental HealthMorristown, US

Sahil V. Kirpekar(President and CEO)Gregory Mayes(Executive Officer, Director)Ellen Lubman(Director)Mark Pollack(Executive Officer)inNathan Bryson(Executive Officer)inMark Theeuwes(Executive Officer)in

Co-investorsMitsui Global Investment MPM BioImpact Novo Holdings

Sequelsequelmedtech.com in

Sequel Med Tech develops wearable insulin delivery devices and precise drug delivery technology for people with diabetes and others, building on the legacy of the insulin pump.

Digital HealthHardwareHealthtechMedical DevicesManchester, US

Co-investorsGraph Ventures Javelin Venture Partners Long Journey Ventures Ulu Ventures

Exits · 1

IPOs and acquisitions across the tracked portfolio

Gynesonicsacq. by Hologic

Portfolio news

latest coverage across their companies

GT Medical Technologies dba GammaTile has filed a notice of an exempt offering of securities to raise $100,056,698.00 in New Funding. - intelligence360

GT Medical Technologies · intelligence360.news · Aug 6, 2026

Evommune Q2 Earnings: $32.2M Net Loss, Trial Data Due | EVMN Stock News

Evommune · stocktitan.net · Aug 6, 2026

Rejoni Raises $25M to Prepare Uterine Healing Hydrogel for FDA Approval and Launch | Femtech Insider

Rejoni · femtechinsider.com · Jul 1, 2026

Kanvas Biosciences Secures $48M Series A to Deliver Novel Microbiome Therapeutics to Cancer Patients

Microbiome Therapeutics · businesswire.com · May 6, 2026

Iantrek Receives $30M in Growth Capital From Trinity Capital

Iantrek · finsmes.com · Apr 29, 2026

News | Hatteras Venture Partners Healthcare Insights

Trefoil Therapeutics · hatterasvp.com · Jan 9, 2026

Reunion Neuroscience expands Series A to $133m after positive trial milestones - Pharmaceutical Technology

Reunion Neuroscience · pharmaceutical-technology.com · Sep 16, 2025

500+ Startups in Biotechnology

BioAesthetics · insights.tryspecter.com · Jun 24, 2025

Frequently asked questions

How many investments has FemHealth Ventures made?: FemHealth Ventures has 24 tracked investments, 1 of which have exited via acquisition or IPO, including 1 dated in the last 24 months.
What stage does FemHealth Ventures invest at?: FemHealth Ventures invests at the Seed, Series A stages.
What sectors does FemHealth Ventures focus on?: FemHealth Ventures focuses on Biotech, Digital Health, FemTech, Healthtech.
Where is FemHealth Ventures located?: FemHealth Ventures is headquartered in Short Hills, US.
Does FemHealth Ventures lead rounds?: FemHealth Ventures typically participates in rounds rather than leading them.
Who does FemHealth Ventures co-invest with?: FemHealth Ventures most often shares deals with Joyance Partners, Ascension Ventures, Delos Capital, among 96 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Episode 186: Maneesha Ghiya of FemHealth Ventures - Amplifying Women in Healthcare and Beyond

Aoifinn Devitt · Maneesha Ghiya

Maneesha Ghiya & Yeenee Leri: FemHealth Ventures

Sarah Schwartz · Maneesha Ghiya

Images

Similar investors

Future Positive Capital

Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.

Lux Capital

Lux Capital is a venture capital firm that backs founders building transformative deep technologies, having been among the first investors in category-defining companies across AI, robotics, biotech, defense, and infrastructure.

$100K – $100M

MedMountain Ventures

MedMountain Ventures (MMV) is an early-stage healthcare investment firm founded by board-certified physicians and seasoned healthcare operators, backing companies that improve patient outcomes and reshape how care is delivered, financed, and accessed.

$500K – $5M

Norwich Ventures

Norwich Ventures is an early-stage venture capital firm focused on medtech, backing entrepreneurs building medical technologies that address large unmet medical needs.

Amzak Health

Amzak Health is a venture investor focused on first-in-class and best-in-class technologies in the medtech and biotech sectors, partnering closely with portfolio company management teams.